
Sign up to save your podcasts
Or
Lilly releases higher dose Zepbound vials, reduces price for patients paying out of pocket. Meanwhile, the tirzepatide lawsuit heats up, with a potential ruing on preliminary injunction. The OFA strikes up a new battle with the FDA, suing them now over the end of the semaglutide shortage.
š Peptide Supplement I Use: https://integrativepeptides.com/AFFILITATES/OTP
SOCIALS:
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
4.9
280280 ratings
Lilly releases higher dose Zepbound vials, reduces price for patients paying out of pocket. Meanwhile, the tirzepatide lawsuit heats up, with a potential ruing on preliminary injunction. The OFA strikes up a new battle with the FDA, suing them now over the end of the semaglutide shortage.
š Peptide Supplement I Use: https://integrativepeptides.com/AFFILITATES/OTP
SOCIALS:
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
336 Listeners
1,225 Listeners
49 Listeners
85 Listeners
1,657 Listeners
390 Listeners
224 Listeners
200 Listeners
32 Listeners
94 Listeners
71 Listeners
157 Listeners
19 Listeners
25 Listeners
20 Listeners